GO Term | Evidence Code | PMID |
---|---|---|
cellular response to toxic substance | ||
positive regulation of translation | ||
retinal metabolic process | ||
epoxygenase P450 pathway |
|
|
cellular response to hydrogen peroxide |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:3071 | gliosarcoma | |
DOID:3074 | giant cell glioblastoma | |
DOID:3078 | anaplastic astrocytoma | |
DOID:3083 | chronic obstructive pulmonary disease | |
DOID:3121 | gallbladder cancer | |
DOID:3156 | hypomelanosis of Ito | |
DOID:3168 | squamous cell neoplasm | |
DOID:3172 | papillary adenoma | |
DOID:3234 | central nervous system lymphoma | |
DOID:3393 | coronary artery disease |
HPO ID | HPO Term |
---|---|
HP:0000593 | Abnormal anterior chamber morphology |
HP:0000603 | Central scotoma |
HP:0000639 | Nystagmus |
HP:0000659 | Peters anomaly |
HP:0001052 | Nevus flammeus |
HP:0001087 | Developmental glaucoma |
HP:0001138 | Optic neuropathy |
HP:0003593 | Infantile onset |
HP:0007759 | Opacification of the corneal stroma |
HP:0007854 | Glaucomatous visual field defect |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
102451045 | PELSI12365 | ||
114045358 | VOMUR04613 | ||
113901109 | BOBOX19805 | ||
100949593 | OTOGA07059 | ||
101073188 | TAKRU40005 | ||
102009223 | CHILA10872 | ||
105733181 | AOTNA11768 | ||
110201392 | PHACI33757 | ||
101049264 | SAIBB11553 | ||
101970101 | ICTTR00334 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024